Clinical trial
Treatment of Hearing Fluctuation in Unilateral Meniere's Disease: A Randomized, Placebo-controlled Clinical Trial of Famciclovir
NCT01526408 is registered in ClinicalTrials.gov with House Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Hearing Fluctuation in Unilateral Meniere's Disease: A Randomized, Placebo-controlled Clinical Trial of Famciclovir
- Lead sponsor
- House Research Institute
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- December 31, 2011
- Completion date
- March 31, 2015
- Enrollment
- 11 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
meniere's disease